COVID 19 News and Research

RSS

Increased levels of OAS1 protein may reduce the severity of COVID-19

Researchers at the Lady Davis Institute (LDI) at the Jewish General Hospital have discovered that increased levels of the protein OAS1 are associated with reduced mortality and less severe disease requiring ventilation among patients with COVID-19.

1 Mar 2021

Study: Role of natural mosquito behavior on malaria transmission

Everyone knows 2 + 2 = 4, but what about mosquitoes plus malaria? Lauren Childs, an assistant professor in the Department of Mathematics at Virginia Tech, says there's an equation for that too.

25 Feb 2021

Genes inherited from parents are responsible for severe COVID-19

For the first time, scientists have discovered the genetic predisposition of severe COVID-19 disease.

24 Feb 2021

Study reveals new therapeutic targets on SARS-CoV-2 Spike protein

Considering the recent COVID-19 pandemic, significant investigations are being made to find out how the SARS-CoV-2 Spike protein binds to a human cell.

From Penn State University 23 Feb 2021

Human monoclonal antibodies can act as biological substitute for chemical antibiotics

In the course of a new and groundbreaking study, led by Dr, Natalia Freund and the doctoral candidate Avia Waston at the Sackler Medical Faculty, the research group succeeded in isolating monoclonal antibodies, which hindered the growth of tuberculosis germs in laboratory mice.

23 Feb 2021

Elevated outdoor air pollution events claw their way into indoor spaces

Just when you thought you could head indoors to be safe from the air pollution that plagues the Salt Lake Valley, new research shows that elevated air pollution events, like horror movie villains, claw their way into indoor spaces.

23 Feb 2021

New gel electrophoresis method allows rapid diagnosis of biomarkers by mass spectrometry

Polyacrylamide gel electrophoresis is a technique that allows high-resolution isolation of proteins separated from biological specimens.

22 Feb 2021

Genes could help determine the intensity of neutralizing antibodies to COVID-19 virus

While neutralizing antibodies form in less than two weeks of a COVID-19 infection, their intensity and durability can differ from one individual to another.

22 Feb 2021

New hydrogel shrinks tumors in melanoma mice model

Recently, messenger RNA, also called mRNA, vaccines, to combat the COVID-19 infection have made headlines worldwide, but researchers have already been experimenting with mRNA vaccines to prevent or cure other illnesses, including certain types of cancer.

18 Feb 2021

Study reveals a major genetic risk factor for severe COVID-19

In 2020, a research team demonstrated that a significant genetic risk factor for severe COVID-19 infection was inherited from Neanderthals.

17 Feb 2021

Machine learning approach to identify drugs that could be repurposed to fight Covid-19

When the Covid-19 pandemic struck in early 2020, doctors and researchers rushed to find effective treatments.

16 Feb 2021

Innovative system allows complete study of SARS-CoV-2 mutant spectrum by ultrasequencing

Researchers have designed a program that allows the complete study of the SARS-CoV-2 mutant spectrum by ultrasequencing.

15 Feb 2021

Researchers identify protein sequences that might be used by SARS-CoV-2 to infect cells

Researchers at EMBL Heidelberg have identified sequences in human proteins that might be used by SARS-CoV-2 to infect cells. They have discovered that the virus might hijack certain cellular processes, and they discuss potentially relevant drugs for treating COVID-19.

12 Feb 2021

New tool reveals potentially risky DNA alterations at site of CRISPR gene repair

Scientists have developed an affordable, downloadable app that scans for potential unintended mistakes when CRISPR is used to repair mutations that cause disease.

12 Feb 2021

Seasonal human coronavirus antibodies not associated with protection against SARS-CoV-2

Past exposure to seasonal coronaviruses (CoVs), which cause the common cold, does not result in the production of antibodies that protect against the novel coronavirus SARS-CoV-2, according to a study led by Scott Hensley, PhD, an associate professor of Microbiology at the Perelman School of Medicine at the University of Pennsylvania.

11 Feb 2021

Traffic reductions caused by COVID-19 shutdowns improved air quality in some states

Dramatic decreases in traffic caused by COVID-19 shutdowns improved air quality in car-dependent states but didn't offset additional forms of pollution in other parts of the country.

11 Feb 2021

New method can help trace nanomaterials in blood and tissues

Consumer products, like food, clothes, and cosmetics, are probably filled with nanomaterials—unknown to people.

11 Feb 2021

Increases in active mobility can significantly lower carbon footprints, study reveals

Swapping the car for walking, cycling and e-biking even just one day a week makes a significant impact on personal carbon emissions in cities.

10 Feb 2021

New therapeutic approach to restore the effectiveness of immune cells

Prompted by the need to improve conventional treatments for people infected with the human immunodeficiency virus (HIV-1), a team from the Institut national de la recherche scientifique (INRS) has identified a therapeutic approach to restore the effectiveness of immune cells.

10 Feb 2021

Certain coronaviruses steal hosts’ genes to evade their immune system

Certain coronaviruses can add some genes, that belong to the host they infected, to their genetic pool. In this manner, they can merge and be less noticeable in the immune system.

9 Feb 2021

COVID 19 News and Research

Increased levels of OAS1 protein may reduce the severity of COVID-19

Study: Role of natural mosquito behavior on malaria transmission

Genes inherited from parents are responsible for severe COVID-19

Study reveals new therapeutic targets on SARS-CoV-2 Spike protein

Human monoclonal antibodies can act as biological substitute for chemical antibiotics

Elevated outdoor air pollution events claw their way into indoor spaces

New gel electrophoresis method allows rapid diagnosis of biomarkers by mass spectrometry

Genes could help determine the intensity of neutralizing antibodies to COVID-19 virus

New hydrogel shrinks tumors in melanoma mice model

Study reveals a major genetic risk factor for severe COVID-19

Machine learning approach to identify drugs that could be repurposed to fight Covid-19

Innovative system allows complete study of SARS-CoV-2 mutant spectrum by ultrasequencing

Researchers identify protein sequences that might be used by SARS-CoV-2 to infect cells

New tool reveals potentially risky DNA alterations at site of CRISPR gene repair

Seasonal human coronavirus antibodies not associated with protection against SARS-CoV-2

Traffic reductions caused by COVID-19 shutdowns improved air quality in some states

New method can help trace nanomaterials in blood and tissues

Increases in active mobility can significantly lower carbon footprints, study reveals

New therapeutic approach to restore the effectiveness of immune cells

Certain coronaviruses steal hosts’ genes to evade their immune system

Quorum Bio: Where Synthetic Biology Meets Sustainable Farming

Diagnostic Biochips: Pioneering Brain Research Tools for the Future

Commercializing Innovation in a Life Sciences Ecosystem

Latest in Genomics